Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Ultimovacs ULTIO Apr 13, 2021 75.80 0.00   
 Umida B UMIDAB Apr 13, 2021 7.12 -1.11   
 Unibap UNIBAP Apr 13, 2021 34.60 +0.29   
 Unlimited Travel Group UTG Apr 13, 2021 10.80 +1.89   
 Upsales Technology UPSALE Apr 13, 2021 89.40 -4.28   
 Urb-it URBIT Apr 13, 2021 2.56 +2.40   
 Vadsbo Switchtech VADS Apr 13, 2021 4.10 -3.76   
 VBG Group B VBGB Apr 13, 2021 180.50 +1.12   
 VEF VEFLSDB Apr 13, 2021 4.01 +2.82   
 Veg of Lund VOLAB Apr 13, 2021 9.62 -0.82   
 Veidekke VEIO Apr 13, 2021 118.00 0.00   
 Veoneer VNESDB Apr 13, 2021 215.80 +3.75   
 Vertiseit B VERTB Apr 13, 2021 21.80 +6.34   
 Veteranpoolen B VPABB Apr 13, 2021 29.20 -0.68   
 VibroSense Dynamics B VSDB Apr 13, 2021 7.52 -5.76   
 Vicore Pharma Holding VICO Apr 13, 2021 23.35 +0.21   
 Viking Supply Ships B VSSABB Apr 13, 2021 54.60 +0.37   
 Vistin Pharma VISTNO Apr 13, 2021 17.00 0.00   
 Vitec Software Group B VITB Apr 13, 2021 396.00 +1.54   
 Vitrolife VITR Apr 13, 2021 276.00 +2.45   
 VNV Global VNV Apr 13, 2021 104.50 +1.36   
 Volati VOLO Apr 13, 2021 106.20 +0.95   
 Volati Pref VOLOPREF Apr 13, 2021 658.00 0.00   
 Volvo A VOLVA Apr 13, 2021 212.80 +0.76   
 Volvo B VOLVB Apr 13, 2021 208.50 +0.82   
 Vow VOWO Apr 13, 2021 46.70 0.00   
 Västsvensk Logistik VASLOG Apr 13, 2021 71.50 0.00   
 Wallenius Wilhelmsen WAWIO Apr 13, 2021 27.00 0.00   
 Wallenstam B WALLB Apr 13, 2021 129.00 +1.18   
 Waystream Holding WAYS Apr 13, 2021 14.60 +2.46   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK